AI in cancer care is the use of artificial intelligence to support cancer risk detection, diagnosis workflows, treatment planning, monitoring, and care operations.

AI in cancer care analyzes clinical data such as images, pathology, genomics, symptoms, and medical records to identify patterns and help care teams prioritize work. It supports clinical decision-making but does not replace physician judgment or assume responsibility for diagnosis or treatment.

Why It Matters

AI is becoming a major part of cancer care because oncology is data-heavy, time-sensitive, and clinically complex. The National Cancer Institute notes that AI is being applied across cancer screening, diagnosis, drug discovery, cancer surveillance, and healthcare delivery.

Adoption is accelerating quickly. Grand View Research estimates the global AI in oncology market at $6.00 billion in 2025, with projected growth to $38.91 billion by 2033. In clinical settings, early evidence shows AI can improve specific workflows. A large prospective study in Germany found AI-supported mammography screening was associated with a 17.6% higher breast cancer detection rate compared with screening without AI support.

For employers and health plans, the value of AI in cancer care is not just automation. It is whether AI helps members get to the right screening, follow-up, diagnosis, treatment review, symptom support, or survivorship care faster, with clinicians accountable for decisions.

How AI in Cancer Care Works

AI in cancer care can support several parts of the cancer journey:

• Risk identification and screening: AI can help analyze risk factors, screening eligibility, family history, and population health data to identify members who may need outreach or guideline-based screening.

• Genomics and biomarker analysis: AI can help organize complex genomic, pathology, and biomarker information so oncology teams can interpret which results may be clinically relevant.

• Treatment planning and monitoring: AI can assist with record review, guideline matching, clinical trial matching, symptom alerts, and care gap identification, but the treatment plan should remain clinician-led.

• Administrative automation: AI can reduce manual work by summarizing records, supporting prior authorization workflows, routing follow-up tasks, and helping care teams act sooner.

Color's Skin Cancer Clinic uses AI to check photo quality and optimize images before dermatologist review. A licensed clinician remains responsible for the medical interpretation and next step.

The safest model is AI-assisted care. In this model, AI improves speed and pattern recognition, while oncologists and licensed clinicians remain responsible for diagnosis, prescribing, test ordering, and clinical decision-making.

AI in Cancer Care in the Context of Employee Benefits

Employers and health plans may encounter AI in cancer care through cancer screening programs, virtual cancer clinics, expert medical opinion, oncology case management, utilization management, symptom monitoring, and survivorship support. The practical question for benefits leaders is not simply whether a vendor uses AI, but how AI is governed, audited, and connected to real clinical action.

A strong benefits strategy should pair AI with licensed cancer care, clear escalation pathways, data privacy controls, and measurable outcomes. In Color's model, AI can accelerate record review, image quality checks, risk identification, and task routing, while clinicians retain authority to diagnose, order, prescribe, and make treatment decisions.

Key Takeaways

• AI in cancer care uses artificial intelligence to support cancer risk detection, imaging workflows, genomics, treatment planning, monitoring, and operations.

• For employers and health plans, AI is most valuable when it helps close care gaps, reduce delays, and connect members to qualified clinical care.

• Color uses AI to accelerate clinical work, not replace it. Oncologists and other licensed clinicians remain responsible for diagnosis, test ordering, prescribing, treatment review, and patient care.

Related Terms
See also: Precision Oncology, Oncology-Led Care, Clinical Cancer Care Management

Frequently Asked Questions

Q: Can AI diagnose cancer?
A: AI can support parts of the diagnostic process, such as image analysis, risk stratification, record review, and pattern detection. A cancer diagnosis should only be made by qualified clinicians using clinical evaluation, pathology, imaging, testing, and medical judgment.

Q: What is the difference between AI-assisted care and AI-led care?
A: AI-assisted care uses artificial intelligence to help clinicians work faster and more consistently. AI-led care implies the technology is directing clinical decisions, which is not the right standard for oncology. In cancer care, decision authority should stay with oncologists and licensed clinicians.

Q: What should employers ask when a cancer vendor uses AI?
A: Employers should ask what the AI does, what data it uses, how it is validated, how bias is monitored, and when a clinician reviews or overrides the output. They should also ask whether AI connects to measurable actions such as completed screenings, faster follow-up, symptom escalation, treatment review, and care gap closure.

Learn how Color applies AI inside an oncology-led clinical model.